Skip to Main Content
Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2006, Issue 1
December 8 2006
Issue Cover

Table of Contents

Ham-Wasserman Lecture

Intracellular Protein Degradation: From a Vague Idea thru the Lysosome and the Ubiquitin-Proteasome System and onto Human Diseases and Drug Targeting
Aaron Ciechanover
View Articletitled, Intracellular Protein Degradation: From a Vague Idea thru the Lysosome and the Ubiquitin-Proteasome System and onto Human Diseases and Drug Targeting

Hemolytic Anemia

Immune Hemolytic Anemia—Selected Topics
Philip C. Hoffman
View Articletitled, Immune Hemolytic Anemia—Selected Topics
Cold Hemolytic Syndrome
Morie A. Gertz
View Articletitled, Cold Hemolytic Syndrome
New Insights into Paroxysmal Nocturnal Hemoglobinuria
Robert A. Brodsky
View Articletitled, New Insights into Paroxysmal Nocturnal Hemoglobinuria

Iron in Hematology

Hepcidin and Its Role in Regulating Systemic Iron Metabolism
Tomas Ganz
View Articletitled, Hepcidin and Its Role in Regulating Systemic Iron Metabolism
Current Approaches to the Management of Hemochromatosis
Pierre Brissot,Frédéric de Bels
View Articletitled, Current Approaches to the Management of Hemochromatosis
New Advances in Iron Chelation Therapy
Alan R. Cohen
View Articletitled, New Advances in Iron Chelation Therapy

Sickle Cell Anemia

Red Cell Exchange in Sickle Cell Disease
Paul S. Swerdlow
View Articletitled, Red Cell Exchange in Sickle Cell Disease
Prevention and Management of Stroke in Sickle Cell Anemia
Orah S. Platt
View Articletitled, Prevention and Management of Stroke in Sickle Cell Anemia
Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease
Hassana Fathallah,George F. Atweh
View Articletitled, Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease

Marrow Failure Syndromes

Inherited Bone Marrow Failure Syndromes: Molecular Features
Akiko Shimamura
View Articletitled, Inherited Bone Marrow Failure Syndromes: Molecular Features
Pathophysiologic Mechanisms in Acquired Aplastic Anemia
Neal S. Young
View Articletitled, Pathophysiologic Mechanisms in Acquired Aplastic Anemia
Making Therapeutic Decisions in Adults with Aplastic Anemia
Judith Marsh
View Articletitled, Making Therapeutic Decisions in Adults with Aplastic Anemia

Pediatric Consultative Hematology

Thrombosis in Infants and Children
Reinhard Schneppenheim,Jeanette Greiner
View Articletitled, Thrombosis in Infants and Children
Immune Thrombocytopenic Purpura of Childhood
Diane J. Nugent
View Articletitled, Immune Thrombocytopenic Purpura of Childhood
Disorders of Neutrophil Number and Function
Peter E. Newburger
View Articletitled, Disorders of Neutrophil Number and Function

Molecular Pharmacogenetics

Pharmacogenetics, Pharmacogenomics and Personalized Medicine: Are We There Yet?
Stella M. Davies
View Articletitled, Pharmacogenetics, Pharmacogenomics and Personalized Medicine: Are We There Yet?
Tumor-Specific Genetic Lesions and Their Influence on Therapy in Pediatric Acute Lymphoblastic Leukemia
James R. Downing,Charles G. Mullighan
View Articletitled, Tumor-Specific Genetic Lesions and Their Influence on Therapy in Pediatric Acute Lymphoblastic Leukemia
Deeper Insights into Hematological Oncology Disorders via Single-Cell Phospho-Signaling Analysis
Garry P. Nolan
View Articletitled, Deeper Insights into Hematological Oncology Disorders via Single-Cell Phospho-Signaling Analysis

Acute Lymphoblastic Leukemia in Adults and Children

Myths and Lessons from the Adult/Pediatric Interface in Acute Lymphoblastic Leukemia
Stephen E. Sallan
View Articletitled, Myths and Lessons from the Adult/Pediatric Interface in Acute Lymphoblastic Leukemia
Treatment of Adult Acute Lymphoblastic Leukemia
Nicola Gökbuget,Dieter Hoelzer
View Articletitled, Treatment of Adult Acute Lymphoblastic Leukemia
Central Nervous System Disease in Acute Lymphoblastic Leukemia: Prophylaxis and Treatment
Ching-Hon Pui
View Articletitled, Central Nervous System Disease in Acute Lymphoblastic Leukemia: Prophylaxis and Treatment

Acute Promyelocytic Leukemia

Treatment of Acute Promyelocytic Leukemia
Miguel A. Sanz
View Articletitled, Treatment of Acute Promyelocytic Leukemia
The Biology of Acute Promyelocytic Leukemia and Its Impact on Diagnosis and Treatment
Francesco Lo-Coco,Emanuele Ammatuna
View Articletitled, The Biology of Acute Promyelocytic Leukemia and Its Impact on Diagnosis and Treatment
Management of APL in Developing Countries: Epidemiology, Challenges and Opportunities for International Collaboration
Raul C. Ribeiro,Eduardo Rego
View Articletitled, Management of APL in Developing Countries: Epidemiology, Challenges and Opportunities for International Collaboration

Acute Myeloid Leukemia

Chromosome Aberrations, Gene Mutations and Expression Changes, and Prognosis in Adult Acute Myeloid Leukemia
Krzysztof Mrózek,Clara D. Bloomfield
View Articletitled, Chromosome Aberrations, Gene Mutations and Expression Changes, and Prognosis in Adult Acute Myeloid Leukemia
FLT3 Mutations: Biology and Treatment
Donald Small
View Articletitled, FLT3 Mutations: Biology and Treatment
Controversies in Treatment of AML: Case-based Discussion
Wendy Stock
View Articletitled, Controversies in Treatment of AML: Case-based Discussion

Myelodysplastic Syndromes

Treatment of the 5q– Syndrome
Pierre Fenaux,Charikleia Kelaidi
View Articletitled, Treatment of the 5q– Syndrome
Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes
James W. Vardiman
View Articletitled, Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes
Clinical Issues in the Management of Patients with Myelodysplasia
Charles A. Schiffer
View Articletitled, Clinical Issues in the Management of Patients with Myelodysplasia

Chronic Myeloid Leukemia

ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring
Timothy Hughes
View Articletitled, ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring
Defining and Managing Imatinib Resistance
Michael J. Mauro
View Articletitled, Defining and Managing Imatinib Resistance
Managing the Patient with Chronic Myeloid Leukemia Through and After Allogeneic Stem Cell Transplantation
Jane F. Apperley
View Articletitled, Managing the Patient with Chronic Myeloid Leukemia Through and After Allogeneic Stem Cell Transplantation

Myeloproliferative Disorders

Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders
Ross L. Levine,Gerlinde Wernig
View Articletitled, Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders
Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era
Ayalew Tefferi
View Articletitled, Classification, Diagnosis and Management of Myeloproliferative Disorders in the <em>JAK2</em>V617F Era
Myeloproliferative Disease in Pregnancy and Other Management Issues
Tiziano Barbui,Guido Finazzi
View Articletitled, Myeloproliferative Disease in Pregnancy and Other Management Issues

Hodgkin Lymphoma

The Management of Patients with Limited-Stage Classical Hodgkin Lymphoma
Mary K. Gospodarowicz,Ralph M. Meyer
View Articletitled, The Management of Patients with Limited-Stage Classical Hodgkin Lymphoma
Utility of Positron Emission Tomography (PET) Scanning in Managing Patients with Hodgkin Lymphoma
Malik E. Juweid
View Articletitled, Utility of Positron Emission Tomography (PET) Scanning in Managing Patients with Hodgkin Lymphoma
Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Lucia Nogová,Thomas Rudiger,Andreas Engert
View Articletitled, Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Chronic Lymphocytic Leukemia

Evolving View of the In-Vivo Kinetics of Chronic Lymphocytic Leukemia B Cells
Nicholas Chiorazzi,Manlio Ferrarini
View Articletitled, Evolving View of the <em>In-Vivo</em> Kinetics of Chronic Lymphocytic Leukemia B Cells
New Prognostic Markers in CLL
Emili Montserrat
View Articletitled, New Prognostic Markers in CLL
Current and Investigational Therapies for Patients with CLL
William G. Wierda
View Articletitled, Current and Investigational Therapies for Patients with CLL

Non-Hodgkin Lymphoma

Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma
Laurie H. Sehn
View Articletitled, Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma
Controversies in Follicular Lymphoma: “Who, What, When, Where, and Why?” (Not Necessarily in That Order!)
Myron S. Czuczman
View Articletitled, Controversies in Follicular Lymphoma: “Who, What, When, Where, and Why?” (Not Necessarily in That Order!)
An Update on Therapy of Primary Central Nervous System Lymphoma
Lisa M. DeAngelis,Fabio M. Iwamoto
View Articletitled, An Update on Therapy of Primary Central Nervous System Lymphoma

T-cell Lymphoma

Pathobiology of Peripheral T-cell Lymphomas
Elaine S. Jaffe
View Articletitled, Pathobiology of Peripheral T-cell Lymphomas
Primary Cutaneous T-Cell Lymphomas
Steven T. Rosen,Christiane Querfeld
View Articletitled, Primary Cutaneous T-Cell Lymphomas
Therapy of Peripheral T/NK Neoplasms
John P. Greer
View Articletitled, Therapy of Peripheral T/NK Neoplasms

Multiple Myeloma

Initial Therapy of Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation
Robert Z. Orlowski
View Articletitled, Initial Therapy of Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation
Thrombotic Complications of Myeloma Therapy
Jeffrey A. Zonder
View Articletitled, Thrombotic Complications of Myeloma Therapy
Bisphosphonate Complications Including Osteonecrosis of the Jaw
Bhoomi Mehrotra,Salvatore Ruggiero
View Articletitled, Bisphosphonate Complications Including Osteonecrosis of the Jaw

Supportive Care of Infections in Patients with Hematologic Malignancies

Of Yeasts and Hyphae: A Hematologist’s Approach to Antifungal Therapy
Eric J. Bow
View Articletitled, Of Yeasts and Hyphae: A Hematologist’s Approach to Antifungal Therapy
Viral Infections in Patients with Hematological Malignancies
James C. Wade
View Articletitled, Viral Infections in Patients with Hematological Malignancies
Viral Hepatitis: Manifestations and Management Strategy
Roberto J. Firpi,David R. Nelson
View Articletitled, Viral Hepatitis: Manifestations and Management Strategy

Reduced-Intensity Allogeneic Bone Marrow Transplantation

Outcomes with Myeloid Malignancies
Bart L. Scott,Brenda M. Sandmaier
View Articletitled, Outcomes with Myeloid Malignancies
Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Issa F. Khouri
View Articletitled, Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Reduced-Intensity Regimens in Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathies
Franco Locatelli
View Articletitled, Reduced-Intensity Regimens in Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathies

Thrombocytopenia

ITP in the 21st Century
Diana S. Beardsley
View Articletitled, ITP in the 21st Century
Think of HIT
Theodore E. Warkentin
View Articletitled, Think of HIT
Thrombotic Thrombocytopenic Purpura: A Moving Target
J. Evan Sadler
View Articletitled, Thrombotic Thrombocytopenic Purpura: A Moving Target

Bleeding Disorders

The Role of Immunomodulation in the Management of Factor VIII Inhibitors
David Lillicrap
View Articletitled, The Role of Immunomodulation in the Management of Factor VIII Inhibitors
Challenges in the Therapeutic Use of a “So-Called” Universal Hemostatic Agent: Recombinant Factor VIIa
W. Keith Hoots
View Articletitled, Challenges in the Therapeutic Use of a “So-Called” Universal Hemostatic Agent: Recombinant Factor VIIa
Acquired Factor VIII Inhibitors: Pathophysiology and Treatment
Alice D. Ma,Daniel Carrizosa
View Articletitled, Acquired Factor VIII Inhibitors: Pathophysiology and Treatment

Thrombophilia

Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological Mechanisms
Agnes Y. Y. Lee
View Articletitled, Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological Mechanisms
Management of Hereditary Hypercoagulable Disorders
Paula L. Bockenstedt
View Articletitled, Management of Hereditary Hypercoagulable Disorders
New Anticoagulants
Kenneth A. Bauer
View Articletitled, New Anticoagulants

Antithrombotic Therapy: Problems and Issues

Perioperative Evaluation of Bleeding Diathesis
Lawrence L.K. Leung
View Articletitled, Perioperative Evaluation of Bleeding Diathesis
Prevention of Venous Thromboembolism in High-Risk Patients
William H. Geerts
View Articletitled, Prevention of Venous Thromboembolism in High-Risk Patients
Pharmacogenetics-Based Coumarin Therapy
Brian F. Gage
View Articletitled, Pharmacogenetics-Based Coumarin Therapy

ASH Special Educational Symposium

Bleeding Disorders in Premenopausal Women: (Another) Public Health Crisis for Hematology?
Andra H. James,Margaret V. Ragni,Vincent J. Picozzi
View Articletitled, Bleeding Disorders in Premenopausal Women: (Another) Public Health Crisis for Hematology?

Updates in Transfusion Medicine: DLI, Platelets, and TRALI

Vaccine-Enhanced Donor Lymphocyte Infusion (veDLI)
John D. Roback
View Articletitled, Vaccine-Enhanced Donor Lymphocyte Infusion (veDLI)
Platelets: Testing, Dosing and the Storage Lesion—Recent Advances
Richard M. Kaufman
View Articletitled, Platelets: Testing, Dosing and the Storage Lesion—Recent Advances
Transfusion-Related Acute Lung Injury: An Update
Darrell J. Triulzi
View Articletitled, Transfusion-Related Acute Lung Injury: An Update

Errata

Appendix A: Errata
View Articletitled, Appendix A: Errata
Appendix A: Errata
View Articletitled, Appendix A: Errata
Appendix A: Errata
View Articletitled, Appendix A: Errata

Appendix: Color Figures

Appendix B: Color Figures
View Articletitled, Appendix B: Color Figures
All Issues
Targeted medical therapies for vascular anomalies
T-cell–based therapies for treating relapsed or refractory mantle cell lymphoma
Transplant in ALL: who, when, and how?
Ph− ALL: immunotherapy in upfront treatment
Ph+ ALL: new approaches for upfront therapy
  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal